Arvinas, Inc. (ARVN)
13.10
-0.22
(-1.61%)
USD |
NASDAQ |
Dec 09, 16:00
13.10
0.00 (0.00%)
After-Hours: 18:31
Arvinas Research and Development Expense (TTM): 306.40M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Assembly Biosciences, Inc. | 61.75M |
| Alnylam Pharmaceuticals, Inc. | 1.248B |
| Verastem, Inc. | 103.74M |
| Sarepta Therapeutics, Inc. | 1.389B |